JOURNAL TRANSCRIPT

---

conferenceseries.com

Tentative Program 29th International Conference on

Vaccines and Immunization London, UK March 19-20, 2018

Theme: “Highlights of latest technologies and innovations in Vaccines and Immunization”

Interactive Sessions

Keynote Lectures Exhibitors

Plenary Lectures

Workshops

B2B

Meetings

***For available speaker slots*** [email protected] www.vaccines-immunization.conferenceseries.com

Tentative Program

conferenceseries.com

29th International Conference on

Vaccines and Immunization London, UK March 19-20, 2018

Program at A Glance

Day 1 Reception/Registration

08:00-09:00

Morning Sessions

Time

Least of 3 Keynote/Plenary Talks

General Session

09:00-09:15

Inaugural Address

09:15-09:45

Keynote/Plenary Talk 1

09:45-10:15

Keynote/Plenary Talk 2

10:15-10:45

Keynote/Plenary Talk 3

Panel Discussions/Group Photo Coffee/Tea Break 10:45-11:00 (Networking)

Evening Sessions

11:00-12:40

5 Speakers (20 Mins Each) Lunch Break 12:40-13:30

13:30-15:30

5 Speakers (20 Mins Each) Coffee/Tea Break 15:30-15:45 (Networking)

15:45-17:25

5 Speakers (20 Mins Each)

Day 2

Evening Sessions

Morning Sessions

Time 09:00-10:40

Session 1

Session 2

Keynote Forum Coffee/Tea Break 10:40-10:55 (Networking)

10:55-12:35

5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each)

Lunch Break 12.35-13.25 13:25-15:05

5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each)

Coffee/Tea Break 15.05-15.20 (Networking) 15.20-17.00

5 Speakers (20 Mins Each)

5 Speakers (20 Mins Each)

Awards & Closing ceremony NOTE: Program Schedule is subject to change with final allotment of the speaker slots For more Details: www.vaccines-immunization.conferenceseries.com [email protected] | [email protected]

www.vaccines-immunization.conferenceseries.com

Conference Highlights • Human Vaccines against Infectious Diseases

• Vaccines & Autism

• Cancer, Malaria & TB Vaccines

• Vaccine Safety & Efficacy

• HIV Vaccines

• Geriatric Immunization

• Immunizations & Bioterrorism

• Vaccines for Pregnant Women & Neonates

• Combination & Conjugate Vaccines

• Vaccines for Unconventional Diseases

• DNA & Synthetic Vaccines

• Animal Models & Clinical Trails

• Travel & Edible Vaccines

• Animal & Plant Derived Vaccines

• Paediatric Vaccination

• Vectors, Adjuvants & Delivery Systems

• Vaccines for Immune Mediated Diseases

• Vaccine Production & Development

• Veterinary Vaccines

• Cellular Immunology & Latest Innovations

• Fish & Poultry Vaccines

• Antibodies: Engineering & Therapeutics

• Vaccines against Drugs‎

• Current Research & Future Challenges

Best Poster Award • You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster • Judges will even evaluate the student’s enthusiasm towards their study, interest and knowledge in the area of their research • The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement • Apart from the judging time you may also be present at the poster to share your research with interested delegates

Young Researchers Forum • Present your research through oral presentations • Learn about career development and the latest research tools and technologies in your field • This forum will give pertinent and timely information to those who conduct research and those who use and benefit from research • Develop a foundation for collaboration among young researchers • The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe • Interact and share ideas with both peers and mentors

Call for Abstract: http://vaccines-immunization.conferenceseries.com/call-for-abstracts.php Abstract Submission: http://vaccines-immunization.conferenceseries.com/abstract-submission. phpRegistration: http://vaccines-immunization.conferenceseries.com/registration.php

www.vaccines-immunization.conferenceseries.com

Glimpses

www.vaccines-immunization.conferenceseries.com

Best Tourist Destinations in London,UK

Big Ben

Buckingham Palace

HMS Belfast

Imperial War Museum

London Bridge

Palace of Westminster www.vaccines-immunization.conferenceseries.com

London Eye

Sea Life Aquarium

About London

London is the capital and most crowded city of England and the United Kingdom. Remaining on the River Thames in the south east of the island of Great Britain, London has been a noteworthy settlement for two centuries. It was established – most likely proximate to an as of now subsisting Celtic Briton town or settlement – around the year 43 by the Romans, who assigned it Londinium. London’s age-old center, the City of London, to a great extent holds its 1.12-square-mile (2.9 km2) medieval limits. Since at any rate the nineteenth century, “London” has furthermore alluded to the city around this center, truly part between Middlesex, Essex, Surrey, Kent, and Hertfordshire, which today to a great extent makes up More prevalent London, represented by the Mayor of London and the London Assembly. London is the leading global city in arts, commerce, finance, fashion, education technology, healthcare, media, transport, tourism, research, and development. London is the global centre for Higher Education and research. According to QS World University Ranking, it has the highest number of international students. It is world’s second most Economical powerful city and has the fifth- or sixth-largest metropolitan area GDP in the world. London is the world’s leading investment destination, which hosts more number of international retailers and ultra high-net-worth individuals. It has world’s largest city Airport System measured by passenger traffic. It is the world’s most visited city measured by international arrivals. London’s wetland areas support nationally important populations of many water birds. London is the home for many wildlife reserves, two National Nature Reserves and 76 Local Nature Reserves, and 38 Sites of Special Scientific Interest (SSSIs). In 2012, London turned into the main city to have facilitated the present day Summer Olympic Games three times. The presence of universities, hospitals, labs and other professional services, together with key installations of the U.K. make it favourite destination for scientific meetings.

Important Dates Abstract submission opens: March 22, 2017 Registration opens: March 22, 2017 Early bird registration: August 25, 2017 On spot registration: March 19, 2018 Contact Details: Abby Olivia Ph: (702) 508-5200 Ext: 8041 Customer Service: +1 (800) 216 6499 Email: [email protected]

www.vaccines-immunization.conferenceseries.com

conferenceseries.com 888th Conference

Scientific Program

15th Annual Summit on

Vaccines and Immunization

February 20-21, 2017 Berlin, Germany

Hosting Organizations: Conference Series LLC 2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA Ph: +1-702-508-5192, Fax: +1-650-618-1417, Toll free: +1-800-216-6499 Conference Series Ltd Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499 Email: [email protected], [email protected]

Day 1 | February 20, 2017 | Monday Registrations

conferenceseries.com

Sylt 1-2

Opening Ceremony Keynote Forum

Keynote Forum

Introduction Title: The VCG platform facilitates mucosal and systemic vaccine delivery for induction of protective immunity in the female genital tract Francis Eko, Morehouse School of Medicine, USA Title: From human vaccines for viral diseases to those ones for oncogenic viruses and tumor antigens Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy

Coffee Break Sessions: Vaccine Delivery Systems and Adjuvants | Vaccine Production and Delivery Technologies | Hepatitis, HIV and STD Vaccines | Vaccination for Emerging and Re-emerging Diseases | Cancer Vaccines Session Chair: Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy Session Co-chair: Yusuf Omosun, Morehouse School of Medicine, USA

Session Introduction

Title: VCG modulate innate and adaptive immunity to vaccine antigens Yusuf Omosun, Morehouse School of Medicine, USA Title: The emerging role of ASC in dendritic cell metabolism and function during chlamydia infection Qing He, Morehouse School of Medicine, USA Title: The use of new adjuvants and VLPs for the development of vaccines for emerging and infectious diseases Gustavo Cabral de Miranda, University of Oxford, UK Title: Pulmonary delivery of a mucosal nanocarrier vaccine for Pneumonia Imran Saleem, Liverpool John Moores University, UK Group Photo Lunch Break Session Chair: Francis Eko, Morehouse School of Medicine, USA Session Co-chair: Talin Barissani-Asenbauer, Medical University of Vienna, Austria Session Introduction Title: Next-generation millisecond manufacture of genetic vaccines and lipid/polymer-based vaccines Nadia Tagnaouti, Precision NanoSystems Inc., Canada Title: A reasonable hope to cure HIV with the Tat Oyi vaccine: Results and follow up of a double blinded randomized phase I/IIa clinical trial in France Erwann Loret, Aix Marseille University, France Title: Evaluation of nanoparticle-delivered inactivated whole antigen against Chlamydia psittaci infection in SPF chickens Cheng He, China Agricultural University, China Title: Mucosal Immunization via conjunctiva: Where do we stand? Talin Barissani-Asenbauer, Medical University of Vienna, Austria Title: Use of corpuscular adjuvants for ocular mucosal immunization as a strategy for vaccine against trachoma Aleksandra Inic-Kanada, Center of Ocular Inflammation and Infection, Austria Coffee Break Title: VVX001- a promising novel hepatitis B vaccine candidate Rainer Henning, Viravaxx AG, Austria Panel Discussion End Of Day 1 Page 8

Day 2 | February 21, 2017 | Tuesday

Sylt 1-2

Keynote Forum Introduction Title: Conjugate rPA-PGA anthrax vaccine induces protective antibodies Lallan Giri, Biologic Resources LLC, USA Title: Development of vaccines using genetically engineered Inoviruses Leondios G Kostrikis, University of Cyprus, Cyprus

Coffee Break Sessions: Biodefense Vaccine against Bioterrorism | Vaccines for Immune Mediated Diseases | Vaccines for Pregnant Women and Neonates | Antibodies : Engineering and Therapeutics | Animal Models and Clinical Trials Session Chair: Leondios G Kostrikis, University of Cyprus, Cyprus Session Co-Chair: Lallan Giri, Biologic Resources LLC, USA Session Introduction Title: Protection against bioterrorism Lallan Giri, Biologics Resources LLC, USA Title: When funding for medical countermeasures against rare, but detrimental agents is cost-effective Mark Lawrence Johnson, MJ Lawrence Consulting, Germany Title: An mRNA-based vaccine technology for next generation prophylactic vaccines Susanne Rauch, CureVac, Germany Title: ATMP Cell Therapy: Triumphs and constraints for unmet clinical needs Shreemanta K Parida, Justus-Liebig University, Germany Lunch Break & Poster Session Title: Efficient expression of porcine circovirus type 2 virus-like particles in Escherichia coli Guanggang Qu, Shandong Binzhou Animal Science and Veterinary Medicine Academy, China Title: Comparison of susceptibility to measles in preterm infants versus term infants Joseph L Mathew, Postgraduate Institute of Medical Education and Research, India Title: Vaccines for key unmet Medical (Infectious Disease) needs in the developing world: Learning and reflections from the India Polio eradication success story Aamir Shaikh, Assansa, India Title: Pneumococcal meningoencefalitis in 50-day-old baby ended with lethal outcome: A case report Liliya Pekova, University hospital (Stara Zagora), Bulgaria Title: Promising results in the assessment of new vaccine candidates against campylobacter in poultry Marine Meunier, French Agency for Food, Environmental and Occupational Health & Safety, France Coffee Break Panel Discussions End Of Day 2 Closing Ceremony

Page 9

conferenceseries.com

Scientific Program

10th Euro Global Summit and Expo on

Vaccines & Vaccination June 16-18, 2016

Hosting Organization: Conference Series LLC

Rome, Italy

2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-702-508-5200 Ext: 8047, Toll free: +1-800-216-6499 e-mail: [email protected]; [email protected]

Day 1

June 16, 2016

Registrations

Appia

conferenceseries.com

Opening Ceremony Keynote Forum

Introduction Title: Development of the full length single chain gp120-CD4 (FLSC), a novel vaccine for HIV prevention Timothy R Fouts, Profectus Biosciences Inc., USA Title: Vaccines moving beyond the next frontier Rene Labatut, Sanofi Pasteur, France Networking & Refreshments Break Title: VGX-3100 drives regression of HPV16/18 CIN2/3 and robust cellular immune responses in blood and cervical tissue in a blinded, randomized, placebo-controlled phase 2b study Prakash Bhuyan, Inovio Pharmaceuticals, USA Group Photo Track 1: Cancer Vaccines Track 2: Vaccine Products and Delivery Technologies Track 3: Vaccine Research and Development Track 4: Vaccines for Respiratory Infections Track 5: HIV Vaccines Track 6: Veterinary vaccines Session Chair: Timothy R Fouts, Profectus Biosciences Inc., USA Session Co-chair: Qingsheng Li, University of Nebraska-Lincoln, USA Session Introduction Title: Pre-clinical evaluation of the therapeutic application of a vaccine targeting the 12 protease cleavage sites Ma Luo, University of Manitoba, Canada Title: Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by live attenuated SIV Qingsheng Li, University of Nebraska-Lincoln, USA Title: TAT, the forgotten target that could help to cure from HIV Erwann P Loret, ETRAV Laboratory, France Title: Community engagement during the Ebola vaccine trial in Guinea Godwin Enwere, World Health Organization, Switzerland Title: Pre-clinical toxicology considerations in vaccine Nabil Al-Humadi, Food and Drug Administration, USA Lunch Break Title: Codon harmonization, a step beyond optimization to capture the natural rhythm of protein translation Bettina Werle, Bioaster, France Title: Development of lipid based oral vaccine formulations Sarah Margaret Hook, University of Otago, New Zealand Title: Viral vectored genetic vaccines: Current status and future perspectives Antonella Folgori, Reithera SRL, Italy Title: Active immunization against proprotein convertase subtilisin/kexin type 9 (PCSK9): A new strategy to control hyperlipidemia Gunther Staffler, AFFiRiS AG, Austria Title: Development of a production and purification platform for virus like particles (VLP) vaccine candidates: A case study Anissa Boumlic-Courtade, Merck Life Science, France Title: MATS: Global coverage estimates for 4CMenB, a novel multi-component meningococcal B vaccine Duccio Medini, GSK Vaccines, Italy Networking & Refreshments Break Title: Implementing a randomized control trial (RCT) in the context of an Ebola epidemic Godwin Enwere, World Health Organization, Switzerland Title: Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge Peter Burkhard, Alpha-O Peptides AG, Switzerland Title: Plant expression platforms for vaccine production Kathleen Hefferon, Cornell University, USA

Page 11

Title: What do Lebanese women know about cervical cancer and human papillomavirus prevention? A report on awareness levels in urban communities Jacques Choucair, Saint Joseph University, Lebanon Young Researchers Forum Title: Isolation and characteristics identification of bovine rotaviruses from vaccinated dairy calves in Morocco Ennima Imane , University Mohammed V of Rabat, Morocco Title: Bluetongue virus (BTV) serological survey and evidence of emergent BTV-8 serotype in Morocco Kamar Drif, Institut Agronomique et Veterinaire Hassan II, Morocco Title: Evaluation of the protection conferred by an attenuated vaccine (Mass-type H120) of avian infectious bronchitis against a new emerging Italy 02 genotype in Moroccan broiler chickens Khadija Khataby, University Hassan II of Casablanca, Morocco Panel Discussion Day 2

June 17, 2016 Appia

Keynote Forum

Title: Towards affordable conjugate vaccines: Efficient chemistry and low cost carrier protein Andrew Lees, Fina Biosolutions LLC, USA

Title: Human vaccines and vaccination for non-infectious diseases

Giulio Filippo Tarro, Foundation T. & L. de Beaumont Bonelli for Cancer Research, Italy

Networking & Refreshments Break Title: Challenges and dilemmas about vaccines against the herpesviruses : The case of EBV Emmanuel Drouet, Université Grenoble-Alpes, France Track 7: Vaccines against Infectious diseases Track 8: Viral Vaccines Track 9: Bacterial Vaccines Track 10: Childhood Vaccines Track 11: Hepatitis Vaccines Track 12: Toxoid Vaccines

Session Chairs: Giulio Filippo Tarro, Foundation T. & L. de Beaumont Bonelli for Cancer Research, Italy Andrew Lees, Fina Biosolutions LLC, USA

Session Introduction

Title: Rapid development of an oral Zika virus vaccine Sean N Tucker, Vaxart Inc., USA Title: Preclinical development of HeV-sG as a vaccine and m102.4 as a post exposure prophylaxis against henipavirus infections Timothy R Fouts, Profectus Bio-Sciences, USA Title: Measles: Need for continued vaccination and novel vaccines post virus eradication S Louise Cosby, Agri-Food and Biosciences Institute, UK Title: Evaluation of genetic stability of transgenes in vaccine Ali Azizi, Sanofi Pasteur, Canada Title: Process development for pneumococcal protein vaccines based on recombinant pneumococcal surface protein A (PspA) and hybrids of PspA and pneumolysin toxoid Viviane Maimoni Goncalves, Instituto Butantan, Brazil Lunch Break Title: The key person influences flu vaccination among health workers: Perspective study of social network Xiaoning Hao, China National Health Development Research Center, China Title: Pneumococcal conjugate vaccine: Use of pneumococcal surface protein A (PspA) as carrier Giovana Cappio Barazzone, Instituto Butantan, Brazil Title: Construction and immunological study on recombinant multi-epitope adenovirus vaccine for influenza virus Hui-jun Lu, Changchun Veterinary Institute of CAAS, China Title: Pneumococcal inactivated whole cell vaccine: Development of the production process Viviane Maimoni Goncalves, Instituto Butantan, Brazil Title: Knowledge, attitude and practices and influencing factors related to seasonal influenza vaccination among healthcare workers in Qingdao, China, 2013-14: A prospective cohort study Xiaoning Hao, China National Health Development Research Center, China Title: Polio outbreak review in the Middle East and polio immunization mop-up campaigns in the Lebanese/Syrian refugees’ context and post campaign results Randa Hamadeh, Ministry of Public Health, Lebanon Networking & Refreshments Break 15:20-15:40 @ Foyer area Title: Prevalence of tuberculin negativity after BCG vaccination in the under five Saudi children and the need for revaccination Fahad Saleh Al-Tayyeb, King Abdulaziz Medical City, KSA Title: Vaccination of hepatitis B in healthy adults: Effect of sex and age, two protocols of revaccination in non-responders Jacques Choucair, Saint Joseph University, Lebanon Page 12

Panel Discussion Breakout Cassia Meeting Room Workshop on Revisiting HIV inactivation, elite controllers, immunogenetics and HIV therapeutic vaccines

Session Chairs: Barbara Ensoli, National AIDS Center-Istituto Superiore di Sanità, Ital Felipe Garcia Alcaide, Hospital Clinic de Barcelona, Spain Title: Expanding the findings of RV144 to South Africa: P5 initiative Glenda Gray, South African Medical Research Council, South Africa Title: Therapeutic vaccination with Tat restores immune homeostasis, promotes proviral DNA decay and induces cross-clade neutralizing antibodies in patients on HAART: Results from phase II clinical trials in Italy and South Africa Barbara Ensoli, National AIDS Center-Istituto Superiore di Sanità, Italy Networking & Refreshments Break Title: Current strategies for HIV remission: The role of therapeutic vaccines Felipe Garcia Alcaide, Hospital Clinic de Barcelona, Spain Title: Synthetic DNA vaccines for difficult mucosal viruses including HIV Jean D. Boyer, Inovio Pharmaceuticals Inc., USA Title: Potential development of inactivated HIV-1 transmitted/founder virus (T/F) vaccine Adan Rios, PhotoImmune Biotechnology Inc., USA Discussion Lunch Break Session Chairs: Marc H.V. Van Regenmortel, Biotechnology School of the University of Strasbourg, France Eric Sandstrom, Karolinska Institutet, Sweden Title: HIV vaccine development: Is a moral wrong occurring? Mike King, University of Otago, New Zealand Title: Reverse HIV vaccinology failed because it has no sound theoretical basis in the case of this virus Marc H.V. Van Regenmortel, Biotechnology School of the University of Strasbourg, France Title: HIV replication is suppressed by CD8+T- regulatory cells in elite controllers Jean Marie Andrieu, Paris-Descartes University, France Title: Concerns in the planning of therapeutic immunizations in HIV infected patients aiming to harness HLA E restricted CD8+T-cell HIV suppressive activity Eric Sandstrom, Karolinska Institutet, Sweden Networking & Refreshments Break Title: Multiple immunogenetic aspects in susceptibility to HIV-1 infection progression toward AIDS and rational vaccine design Massimo Amicosante, University of Rome, Italy Workshop Discussion Poster Presentations

EVACC 01 EVACC 02 EVACC 03 EVACC 04 EVACC 05 EVACC 06 EVACC 07 EVACC 08 EVACC 09

Role of insulin like growth factor-1 derived from macrophages in an influenza vaccine induced humoral immune response Jae-Hwan Nam, Catholic University of Korea, South Korea Visualization of immune response to hepatitis B vaccination by in vivo small animal imaging Hyewon Youn, Seoul National University, South Korea Development immunogen for protection against PRRSV infection using Korean isolates ORF5 protein expression using baculovirus expression system Sun Shin Yi, Soonchunhyang University, South Korea Vaccine potentials of excretory-secretory antigens of 4 week old juveniles against Fasciola gigantica in mice Narin Changklungmoa, Burapha University, Thailand Vaccine potentials of recombinant mature cathepsin L1H against Fasciola gigantica in mice Pornanan Kueakhai, Burapha University, Thailand Characterization and vaccination of the cytosolic Fasciola gigantica superoxide dismutase Wipaphorn Jaikua, Mahidol University, Thailand Study for manufacture and establishment of 1st national standard material for cell derived Japanese encephalitis vaccine (Beijing strain) Ji Young Hong, National Institute of Food and Drug Safety Evaluation, Korea Histone deacetylase 10 (HDAC 10) deacetylates Foxp3 and modulates its stability Suna Gu, Chonbuk National University, Republic of Korea In silico design of epitope based peptide vaccine against virulent strains of HN-Newcastle disease virus (NDV) in poultry species Marwa Mohamed Osman, Africa City of Technology, Sudan

Page 13

Track 13: DNA Vaccines Track 14: Vaccine Safety and Efficacy Track 15: Vaccine Adjuvants Track 16: Tuberculosis Vaccines Track 17: Vaccination for Pregnant Women Track 18: Human Preventive and Therapeutic Vaccines

Day 3 Appia

Session Chair: Emmanuel Drouet, Université Grenoble-Alpes, France Session Co-Chair: Sheikh Mohammad Fazle Akbar, Toshiba General Hospital, Japan

Session Introduction Title: Vaccines for pregnant women - challenges and opportunities for harmonized safety monitoring Sonali Kochhar, Global Healthcare Consulting, India Title: Exploiting a high dose murine challenge model for HSV to identify potential DNA prime subunit boost vaccine strategies that could be translated to human clinical trials Timothy R Fouts, Profectus Biosciences Inc., USA Networking & Refreshments Break Title: Operational experience and lessons learned on influenza vaccination post authorization safety studies Ombretta Palucci, Quintiles, Switzerland Title: Post-marketing surveillance of BCG vaccination Ruwen Jou, Tuberculosis Research Center at Centers for Disease Control, Taiwan Title: Novel vaccine adjuvants for animal infectious diseases Jishu Shi, Kansas State University, USA Title: Emerging market challenges: Development of a thermostable and immunologically active solid HPV vaccine formulation Ramesh Chintala, Merck & Co. Inc., USA Lunch Break Title: Immunogenicity of VLP forming baculoviral DNA vaccine Young Bong Kim, Konkuk University, Republic of Korea Title: Targeting TLR9 and TLR21 to develop vaccine adjuvant for different species Tsung-Hsien Chuang, National Health Research Institutes, Taiwan Title: Therapeutic vaccines for treatment of allergic and autoimmune diseases Zhikang Peng, University of Manitoba, Canada Title: Therapeutic vaccines against chronic hepatitis-B virus and related complications Sheikh Mohammad Fazle Akbar, Toshiba General Hospital, Japan Panel Discussion & Closing Ceremony

Bookmark your dates 18th International Conference on

Vaccine Adjuvatns Delivery Technologies July 27-28, 2017 Chicago, USA e-mail: mailto:[email protected]" [email protected] Website: http://vaccinedelivery.conferenceseries.com/ Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169 Fax: +1-650-618-1417 [email protected]

Conference Series Ltd. Traian Str., No.61, Constanta 900720, Romania, Tel: 0805-080048 Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, United Kingdom [email protected]

OMICS International 6th Floor, North Block, Divyasree Building, Raidurg Hyderabad, Telangana, INDIA-500032 Tel: +91-40-33432300 [email protected]

Toll free USA & Canada: +1-800-216-6499 Australia: +1-800-651-097 Europe: 0805-080048